Advertisement

Stress and Pregnancy: CRF as Biochemical Marker

  • P. Florio
  • F. M. Reis
  • S. Luisi
  • M. De Bonis
  • I. Zerbetto
  • R. Battista
  • M. Quadrifoglio
  • C. Ferretti
  • A. Dell’Anna
  • M. Palumbo
  • F. Petraglia

Abstract

The initiation, maintenance and termination of pregnancy are related to placental functions, as the human placenta contributes to maintaining equilibrium between the fetus and the mother and regulating the bodily functions of both organisms in a complementary way. This is made possible through the secretion of several growth factors, neurohormones and cytokines by human placenta [1, 2, 3].

Keywords

Human Placenta Maternal Plasma Fetal Membrane Human Myometrium Myometrial Contractility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Petraglia F, Volpe A, Genazzani AR et al (1990) Neuroendocrinology of the human placenta. Front Neuroendocrinol 11:6–37Google Scholar
  2. 2.
    Reis FM, Florio P, Cobellis L et al (2001) Human placenta as a source of neuroendocrine factors. Biol Neonate 79:150–156PubMedCrossRefGoogle Scholar
  3. 3.
    Petraglia F, Sawchenko PE, Rivier J, Vale W (1987) Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 328:717–719PubMedCrossRefGoogle Scholar
  4. 4.
    Petraglia F, Tabanelli S, Galassi MC et al (1992) Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. J Clin Endocrinol Metab 74:1427–1431PubMedCrossRefGoogle Scholar
  5. 5.
    Vale W, Rivier C, Brown MR et al (1983) Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 39:245–270PubMedGoogle Scholar
  6. 6.
    Orth DN (1992) Corticotropin-releasing hormone in humans. Endocr Rev 13:164–191PubMedCrossRefGoogle Scholar
  7. 7.
    Vaughan J, Donaldson C, Bittencourt J et al (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287–292PubMedCrossRefGoogle Scholar
  8. 8.
    Liaw CW, Lovenmerg TW, Barry G et al (1996) Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137:72–77PubMedCrossRefGoogle Scholar
  9. 9.
    Valdenaire O, Giller T, Breu V et al (1997) A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochim Biophys Acta 1352:129–132PubMedGoogle Scholar
  10. 10.
    Chen R, Lewis K, Perrin MH, Vale W (1993) Expression and cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci U S A 90:8967–8971PubMedCrossRefGoogle Scholar
  11. 11.
    Petraglia F, Florio P, Gallo R et al (1996) Corticotropin-releasing factor-binding protein: origins and possible functions. Horm Res 45:187–191PubMedGoogle Scholar
  12. 12.
    Potter E, Behan DP, Fischer WH et al (1991) Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 349:423–426PubMedCrossRefGoogle Scholar
  13. 13.
    Potter E, Behan DP, Linton EA et al (1992) The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci U S A 89:4192–4196PubMedCrossRefGoogle Scholar
  14. 14.
    Saijonmaa X, Laatikainen T, Wahlstrom T (1988) Corticotropin releasing factor in human placenta: localization, concentration and release in vitro. Placenta 9:373–385PubMedCrossRefGoogle Scholar
  15. 15.
    Riley SC, Walton JC, Herlick JM, Challis JR (1991) The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 72:1001–1007PubMedGoogle Scholar
  16. 16.
    Frim DM, Emanuel RL, Robinson BG et al (1988) Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J Clin Invest 82:287–292PubMedGoogle Scholar
  17. 17.
    Jones SA, Brooks AN, Challis JR (1989) Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab 68:825–830PubMedGoogle Scholar
  18. 18.
    Riley SC, Challis JR (1991) Corticotropin-releasing hormone production by the placenta and fetal membranes. Placenta 12:105–119PubMedCrossRefGoogle Scholar
  19. 19.
    Petraglia F, Florio P, Gallo R et al (1996) Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 81:3807–3810PubMedCrossRefGoogle Scholar
  20. 20.
    Florio P, Rivest S, Reis FM et al (1999) Lack of gestational-related changes of urocortin gene expression in human placenta. Prenat Neonat Med 4:296–300Google Scholar
  21. 21.
    Karteris E, Grammatopoulos D, Dai Y et al (1998) The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1α (CRH-1α) and the CRH-C variant receptor. J Clin Endocrinol Metab 83:1376–1379PubMedCrossRefGoogle Scholar
  22. 22.
    Florio P, Franchini A, Reis FM et al (2000) Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA. Placenta 21:32–37PubMedCrossRefGoogle Scholar
  23. 23.
    Rodrýguez-Linares B, Linton EA, Phaneuf S (1998) Expression of corticotropin releasing hormone (CRH) receptor mRNA and protein in the human myometrium. J Endocrinol 156:15–21CrossRefGoogle Scholar
  24. 24.
    Grammatopoulos D, Dai Y, Chen J et al (1998) Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 83:2539–2544PubMedCrossRefGoogle Scholar
  25. 25.
    Di Blasio AM, Giraldi FP, Vigano P et al (1997) Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J Clin Endocrinol Metab 82:1594–1597PubMedCrossRefGoogle Scholar
  26. 26.
    Petraglia F, Potter E, Cameron VA et al (1993) Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 77:919–924PubMedCrossRefGoogle Scholar
  27. 27.
    Chrousos GP (1998) Editorial: ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity — a dynamic digital-to-analog modulation. Endocrinology 139:437–440PubMedCrossRefGoogle Scholar
  28. 28.
    Chrousos GP, Gold PW (1992) The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 267:1252CrossRefGoogle Scholar
  29. 29.
    Waddell BJ, Burton PJ (1993) Release of bioactive ACTH by perifused human placenta at early and late gestation. J Endocrinol 136:345–353PubMedGoogle Scholar
  30. 30.
    Smith R, Thomson M (1991) Neuroendocrinology of the hypothalamo-pituitary-adrenal axis in pregnancy and the puerperium. Baillieres Clin Endocrinol Metab 5:167–186PubMedCrossRefGoogle Scholar
  31. 31.
    Cooper ES, Greer IA, Brooks AN (1996) Placental proopiomelanocortin gene expression, adrenocorticotropin tissue concentrations, and immunostaining increase throughout gestation and are unaffected by prostaglandins, antiprogestins, or labor. J Clin Endocrinol Metab 81:4462–4469PubMedCrossRefGoogle Scholar
  32. 32.
    Woods RJ, Kennedy KM, Gibbins JM et al (1994) Corticotropin releasing factor binding protein dimerizes after association with ligand. Endocrinology 135:768–773PubMedCrossRefGoogle Scholar
  33. 33.
    Petraglia F, Florio P, Gallo R et al (1996) Corticotropin-releasing factor-binding protein: origins and possible functions. Horm Res 45:187–191PubMedGoogle Scholar
  34. 34.
    Woods RJ, Grossman A, Saphier P et al (1994) Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clereance of the complex. J Clin Endocrinol Metab 78:73–76PubMedCrossRefGoogle Scholar
  35. 35.
    Petraglia F, Florio P, Benedetto C et al (1999) Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J Clin Endocrinol Metab 84:1420–1423PubMedCrossRefGoogle Scholar
  36. 36.
    Jones SA, Challis JR (1989) Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta. Biochem Biophys Res Commun 159:192–199PubMedCrossRefGoogle Scholar
  37. 37.
    Petraglia F, Benedetto C, Florio P et al (1995) Effect of corticotropin-releasing factorbinding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro. J Clin Endocrinol Metab 80:3073–3076PubMedCrossRefGoogle Scholar
  38. 38.
    Jones SA, Challis JR (1990) Effects of corticotropin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes. Gynecol Obstet Invest 29:165–168PubMedCrossRefGoogle Scholar
  39. 39.
    Leitch IM, Boura AL, Botti C et al (1998) Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 83:4510–4513PubMedCrossRefGoogle Scholar
  40. 40.
    Florio P, Lombardo M, Gallo R et al (1996) Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells. Placenta 17:307–311PubMedCrossRefGoogle Scholar
  41. 41.
    Clifton VL, Read MA, Leitch IM et al (1994) Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab 79:666–669PubMedCrossRefGoogle Scholar
  42. 42.
    Clifton VL, Owens PC, Robinson PJ, Smith R (1995) Identification and characterization of a corticotrophin-releasing hormone receptor in human placenta. Eur J Endocrinol 133:591–597PubMedGoogle Scholar
  43. 43.
    Clifton VL, Read MA, Leitch IM et al (1995) Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxidecyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 80:2888–2893PubMedCrossRefGoogle Scholar
  44. 44.
    Petraglia F (1996) Endocrine role of the placenta and related membranes. Eur J Endocrinol 135:166–167PubMedGoogle Scholar
  45. 45.
    Torpy DJ, Chrousos GP (1996) The three-way interactions between the hypothalamicpituitary-adrenal and gonadal axes and the immune system [review]. Baillieres Clin Rheumatol 10:181–198PubMedCrossRefGoogle Scholar
  46. 46.
    Leitch IM, Boura AL, Botti C et al (1998) Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 83:4510–4513PubMedCrossRefGoogle Scholar
  47. 47.
    Boura AL, Walters WA, Read MA, Leitch IM (1994) Autacoids and control of human placental blood flow [review]. Clin Exp Pharmacol Physiol 21:737–748PubMedCrossRefGoogle Scholar
  48. 48.
    Simoncini T, Apa R, Reis FM et al (1999) Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 84:2802–2806PubMedCrossRefGoogle Scholar
  49. 49.
    Challis JR, Sloboda D, Matthews SG et al (2001) The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health [review]. Mol Cell Endocrinol 185:135–144PubMedCrossRefGoogle Scholar
  50. 50.
    Karteris E, Hillhouse EW, Grammatopoulos D (2004) Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility. Endocrinology 145:890–900PubMedCrossRefGoogle Scholar
  51. 51.
    Grammatopoulos DK, Hillhouse EW (1999) Role of corticotropin-releasing hormone in onset of labour. Lancet 354:1546–1549PubMedCrossRefGoogle Scholar
  52. 52.
    Benedetto C, Petraglia F, Marozio L et al (1994) Corticotropin releasing hormone increases prostaglandin F2a activity on human myometrium. Am J Obstet Gynecol 171:126–131PubMedGoogle Scholar
  53. 53.
    Quartero HW, Fry CH (1989) Placental corticotrophin releasing factor may modulate human parturition. Placenta 10:439–443PubMedCrossRefGoogle Scholar
  54. 54.
    Quartero HW, Srivatsa G, Gillham B (1992) Role for cyclic adenosine monophosphate in the synergistic interaction between oxytocin and corticotrophin-releasing factor in isolated human gestational myometrium. Clin Endocrinol (Oxf) 36:141–145Google Scholar
  55. 55.
    Hillhouse EW, Grammatopoulos DK (2000) CRH and urocortin actions during human pregnancy and labour. Stress 4:235–246Google Scholar
  56. 56.
    Robinson BG, Emanuel RL, Frim DM, Majzoub JA (1988) Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci U S A 85:5244–5348PubMedCrossRefGoogle Scholar
  57. 57.
    Challis JRG, Matthews SG, Gibb W, Lye SJ (2000) Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21:514–550PubMedCrossRefGoogle Scholar
  58. 58.
    Stalla GK, Bost H, Stalla J (1989) Human corticotropin-releasing hormone during pregnancy. Gynecol Endocrinol 3:1–10PubMedGoogle Scholar
  59. 59.
    Campbell EA, Linton EA, Wolfe CDA et al (1987) Plasma corticotropin releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 63:1054–1059CrossRefGoogle Scholar
  60. 60.
    Petraglia F, Florio P, Benedetto C et al (1996) High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension. J Clin Endocrinol Metab 81:852–856PubMedCrossRefGoogle Scholar
  61. 61.
    Economides D, Linton E, Nicolaides K et al (1987) Relationship between maternal and fetal corticotrophin-releasing hormone-41 and ACTH levels in human mid-trimester pregnancy. J Endocrinol 114:497–501PubMedGoogle Scholar
  62. 62.
    Suda T, Iwashita M, Sumitomo T et al (1991) Presence of CRH-binding protein in amniotic fluid and in umbilical cord plasma. Acta Endocrinol 125:165–169PubMedGoogle Scholar
  63. 63.
    Linton EA, Wolfe CDA, Behan D, Lowry PJ (1988) A specific carrier substance for human corticotropin releasing factor in late gestational maternal plasma which could mask the ACTH releasing activity. Clin Endocrinol 28:315–324Google Scholar
  64. 64.
    Orth DN, Mount CD (1987) Specific high affinity binding protein for human corticotropin releasing hormone in normal human plasma. Biochem Biophys Res Commun 143:411–417PubMedCrossRefGoogle Scholar
  65. 65.
    Linton EA, Perkins AV, Woods RJ et al (1993) Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J Clin Endocrinol Metab 76:260–262PubMedCrossRefGoogle Scholar
  66. 66.
    Goland RS, Wardlaw SL, Stark RI et al (1986) High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 63:1199–1203PubMedGoogle Scholar
  67. 67.
    Petraglia F, Giardino L, Coukos G et al (1990) Corticotropin-releasing factor and parturition: plasma and amniotic fluid levels and placental binding sites. Obstet Gynecol 75:784–790PubMedGoogle Scholar
  68. 68.
    McLean M, Bisit A, Davies JJ et al (1995) A placental clock controlling the length of human pregnancy. Nat Med 1:460–463PubMedCrossRefGoogle Scholar
  69. 69.
    Florio P, Woods RJ, Genazzani AR et al (1997) Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor. J Clin Endocrinol Metab 82:835–838PubMedCrossRefGoogle Scholar
  70. 70.
    Florio P, Cobellis L, Woodman J et al (2002) Levels of maternal plasma corticotropin-releasing factor (CRF) and urocortin at labor. J Soc Gynecol Investig 9:233–237PubMedCrossRefGoogle Scholar
  71. 71.
    Korebrit C, Ramirez MM, Watson L et al (1998) Maternal corticotropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab 83:1585–1591CrossRefGoogle Scholar
  72. 72.
    Berkowitz GS, Lapinski RH, Lockwood CJ et al (1996) Corticotropin-releasing factor and its binding protein: maternal serum levels in term and preterm deliveries. Am J Obstet Gynecol 174:1477–1483PubMedCrossRefGoogle Scholar
  73. 73.
    Perkins AV, Eben F, Wolfe CD et al (1993) Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy. J Endocrinol 138:149–157PubMedGoogle Scholar
  74. 74.
    Erickson K, Thorsen P, Chrousos G et al (2001) Preterm birth: associated neuroendocrine, medical, and behavioral risk factors. J Clin Endocrinol Metab 86, 2544–2552PubMedCrossRefGoogle Scholar
  75. 75.
    Reis FM, D’Antona D, Petraglia F (2002) Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 23:230–257PubMedCrossRefGoogle Scholar
  76. 76.
    Petraglia F, Florio P, Nappi C, Genazzani AR (1996) Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocrine Rev 17:156–186CrossRefGoogle Scholar
  77. 77.
    Reis FM, Fadalti M, Florio P, Petraglia F (1996) Putative role of placental corticotropin-releasing factor in the mechanisms of human parturition. J Soc Gynecol Invest 6:109–119CrossRefGoogle Scholar
  78. 78.
    Florio P, Severi FM, Ciarmela P et al (2002) Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family. Endocrine 19:91–102PubMedCrossRefGoogle Scholar
  79. 79.
    Florio P, Petraglia F (2002) Human placental corticotropin-releasing factor (CRF) in the adaptive response to pregnancy. Stress 4:247–261CrossRefGoogle Scholar
  80. 80.
    Lowry PJ, Woods RJ, Baigent S (1996) Corticotropin-releasing factor and its binding protein. Pharmacol Biochem Behav 54:305–308PubMedCrossRefGoogle Scholar
  81. 81.
    Petraglia F, Garuti GC, De Ramundo B et al (1990) Mechanism of action of interleukin-1 beta in increasing corticotropin-releasing factor and adrenocorticotropin hormone release from cultured human placental cells. Am J Obstet Gynecol 163:1307–1312PubMedGoogle Scholar
  82. 82.
    Angioni S, Petraglia F, Gallinelli A et al (1993) Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci 53:1735–1742PubMedCrossRefGoogle Scholar
  83. 83.
    Redman CWG (1991) Pre-eclampsia and placenta. Placenta 12:301–308PubMedCrossRefGoogle Scholar
  84. 84.
    Talosi G, Endreffy E, Turi S, Nemeth I (2000) Molecular and genetic aspects of preeclampsia: state of the art. Mol Genet Metab 71:565–572PubMedCrossRefGoogle Scholar
  85. 85.
    Roberts JM, Cooper DW (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357:53–56PubMedCrossRefGoogle Scholar
  86. 86.
    Luckas MJ, Sandland R, Hawe J et al (1998) Fetal growth retardation and second trimester maternal serum human chorionic gonadotrophin levels. Placenta 19:143–147PubMedCrossRefGoogle Scholar
  87. 87.
    Wolfe CD, Patel SP, Campbell EA et al (1988) Plasma corticotrophin-releasing factor (CRF) in normal pregnancy. Br J Obstet Gynaecol 95:997–1002PubMedGoogle Scholar
  88. 88.
    Wolfe CD, Patel SP, Linton EA et al (1988) Plasma corticotrophin-releasing factor (CRF) in abnormal pregnancy. Br J Obstet Gynaecol 95:1003–1006PubMedGoogle Scholar
  89. 89.
    Jeske W, Soszynski P, Lukaszewicz E et al (1990) Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinol (Copenh) 122:711–714Google Scholar
  90. 90.
    Laatikainen T, Virtanen T, Kaaja R et al (1991) Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 39:19–24PubMedCrossRefGoogle Scholar
  91. 91.
    Perkins AV, Linton EA, Eben F et al (1995) Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol 102:118–122PubMedGoogle Scholar
  92. 92.
    Goland RS, Conwell IM, Jozak S (1995) The effect of pre-eclampsia on human placental corticotrophin-releasing hormone content and processing. Placenta 16:375–382PubMedCrossRefGoogle Scholar
  93. 93.
    Goland RS, Jozak S, Warren WB et al (1993) Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol Metab 77:1174–1179PubMedCrossRefGoogle Scholar
  94. 94.
    Ahmed I, Glynn BP, Perkins AV et al (2000) Processing of procorticotropin-releasing hormone (pro-CRH): molecular forms of CRH in normal and preeclamptic pregnancy. J Clin Endocrinol Metab 85:755–764PubMedCrossRefGoogle Scholar
  95. 95.
    Giles W, O’Callaghan S, Read M et al (1997) Placental nitric oxide synthase activity and abnormal umbilical artery flow velocity waveforms. Obstet Gynecol 89:49–52PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • P. Florio
    • 1
  • F. M. Reis
    • 1
  • S. Luisi
    • 1
  • M. De Bonis
    • 1
  • I. Zerbetto
    • 1
  • R. Battista
    • 1
  • M. Quadrifoglio
    • 1
  • C. Ferretti
    • 1
  • A. Dell’Anna
    • 1
  • M. Palumbo
    • 2
  • F. Petraglia
    • 1
  1. 1.Division of Obstetrics and Gynecology, Department of Pediatrics, Obstetrics and Reproductive MedicineUniversity of SienaSienaItaly
  2. 2.Department of Microbiological and Gynecological ScienceUniversity of CataniaSiena and CataniaItaly

Personalised recommendations